Astellas buys gene therapy company Quethera
Astellas Pharma has acquired UK-based Quethera, a gene therapy company. According to terms of the deal, Astellas may pay up to 85 million pounds to Quethera shareholders. Quethera was backed by UK Innovation and Science Seed Fund and Cambridge Enterprise.
10 August 2018•3 mins read
